Why Aon's CEO Is Betting on GLP-1 and Other Weight-Loss Meds
Why Aon's CEO Is Betting on GLP-1 and Other Weight-Loss Meds
"The economic implications for the U.S. are profound," said Greg Case, CEO of Aon.
5:28